PL119444B1 - Method for manufacturing racemic monohydrate of 3-/2-/3-tert.butylamino-2-hydroxypropoxy-/phenyl/-6-hydrazinpyridazine dihydrochloriderata 3-/2-/-3-iii-porjad.butilamino-2-gidroksipropoksi/genil/-6-gidrazinpiridozina - Google Patents
Method for manufacturing racemic monohydrate of 3-/2-/3-tert.butylamino-2-hydroxypropoxy-/phenyl/-6-hydrazinpyridazine dihydrochloriderata 3-/2-/-3-iii-porjad.butilamino-2-gidroksipropoksi/genil/-6-gidrazinpiridozina Download PDFInfo
- Publication number
- PL119444B1 PL119444B1 PL1978209407A PL20940778A PL119444B1 PL 119444 B1 PL119444 B1 PL 119444B1 PL 1978209407 A PL1978209407 A PL 1978209407A PL 20940778 A PL20940778 A PL 20940778A PL 119444 B1 PL119444 B1 PL 119444B1
- Authority
- PL
- Poland
- Prior art keywords
- tert
- monohydrate
- phenyl
- hydroxypropoxy
- butylamino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB7832312 | 1978-08-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL209407A1 PL209407A1 (enExample) | 1980-05-19 |
| PL119444B1 true PL119444B1 (en) | 1981-12-31 |
Family
ID=10498866
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1978209407A PL119444B1 (en) | 1978-08-04 | 1978-09-04 | Method for manufacturing racemic monohydrate of 3-/2-/3-tert.butylamino-2-hydroxypropoxy-/phenyl/-6-hydrazinpyridazine dihydrochloriderata 3-/2-/-3-iii-porjad.butilamino-2-gidroksipropoksi/genil/-6-gidrazinpiridozina |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP0007930B1 (enExample) |
| JP (1) | JPS6040424B2 (enExample) |
| AR (1) | AR223327A1 (enExample) |
| AT (1) | AT361001B (enExample) |
| BG (1) | BG34335A3 (enExample) |
| CA (1) | CA1098522A (enExample) |
| CS (1) | CS204035B2 (enExample) |
| DD (1) | DD138656A5 (enExample) |
| DE (1) | DE2862214D1 (enExample) |
| DK (1) | DK147761C (enExample) |
| EG (1) | EG13469A (enExample) |
| ES (1) | ES473056A1 (enExample) |
| FI (1) | FI64585C (enExample) |
| GR (1) | GR64897B (enExample) |
| HU (1) | HU181959B (enExample) |
| IE (1) | IE47555B1 (enExample) |
| IL (1) | IL55455A (enExample) |
| IN (1) | IN148775B (enExample) |
| IT (1) | IT1110169B (enExample) |
| MT (1) | MTP851B (enExample) |
| MX (1) | MX5425E (enExample) |
| NO (1) | NO783005L (enExample) |
| NZ (1) | NZ188281A (enExample) |
| OA (1) | OA06046A (enExample) |
| PL (1) | PL119444B1 (enExample) |
| SU (1) | SU897110A3 (enExample) |
| YU (1) | YU209078A (enExample) |
| ZA (1) | ZA785008B (enExample) |
| ZM (1) | ZM8078A1 (enExample) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE42214B1 (en) * | 1974-06-18 | 1980-07-02 | Smith Kline French Lab | Hydrazinopyredazines |
-
1978
- 1978-08-21 IN IN619/DEL/78A patent/IN148775B/en unknown
- 1978-08-22 IE IE1702/78A patent/IE47555B1/en unknown
- 1978-08-28 NZ NZ188281A patent/NZ188281A/xx unknown
- 1978-08-28 GR GR57100A patent/GR64897B/el unknown
- 1978-08-29 IL IL55455A patent/IL55455A/xx unknown
- 1978-08-29 JP JP53106180A patent/JPS6040424B2/ja not_active Expired
- 1978-08-30 EG EG541/78A patent/EG13469A/xx active
- 1978-08-31 IT IT27234/78A patent/IT1110169B/it active
- 1978-09-01 HU HU78SI1646A patent/HU181959B/hu unknown
- 1978-09-01 ZA ZA00785008A patent/ZA785008B/xx unknown
- 1978-09-01 CA CA310,530A patent/CA1098522A/en not_active Expired
- 1978-09-04 EP EP78300341A patent/EP0007930B1/en not_active Expired
- 1978-09-04 YU YU02090/78A patent/YU209078A/xx unknown
- 1978-09-04 PL PL1978209407A patent/PL119444B1/pl unknown
- 1978-09-04 OA OA56598A patent/OA06046A/xx unknown
- 1978-09-04 ES ES473056A patent/ES473056A1/es not_active Expired
- 1978-09-04 BG BG040811A patent/BG34335A3/xx unknown
- 1978-09-04 DD DD78207634A patent/DD138656A5/xx unknown
- 1978-09-04 DE DE7878300341T patent/DE2862214D1/de not_active Expired
- 1978-09-04 CS CS785723A patent/CS204035B2/cs unknown
- 1978-09-04 AT AT638378A patent/AT361001B/de not_active IP Right Cessation
- 1978-09-04 NO NO783005A patent/NO783005L/no unknown
- 1978-09-04 DK DK389378A patent/DK147761C/da not_active IP Right Cessation
- 1978-09-04 MX MX787372U patent/MX5425E/es unknown
- 1978-09-04 FI FI782705A patent/FI64585C/fi not_active IP Right Cessation
- 1978-09-04 SU SU782660649A patent/SU897110A3/ru active
- 1978-09-05 AR AR273573A patent/AR223327A1/es active
- 1978-09-15 ZM ZM80/78A patent/ZM8078A1/xx unknown
-
1979
- 1979-07-23 MT MT851A patent/MTP851B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1720531B1 (en) | New compositions containing quinoline compounds | |
| JP3639532B2 (ja) | メロキシカムの経口投与用新規ガレヌス調製物 | |
| RU2483065C2 (ru) | Соли 4-метил-n-[3-(4-метилимидазол-1-ил)-5-трифторметилфенил]-3-(4-пиридин-3-илпиримидин-2-иламино) бензамида | |
| US8754104B2 (en) | Crystalline salts of quinoline compounds and methods for preparing them | |
| JP2008509953A (ja) | ４−［［（７ｒ）−８−シクロペンチル−７−エチル−５，６，７，８−テトラヒドロ−５−メチル−４−６−オキソ−２−ピペリジニル］アミノ］−３−メトキシ−ｎ−（１−メチル−４−ピペリジニル）ベンズアミドの水和物及び多形、その製造方法、並びにその薬物としての使用 | |
| HU193557B (en) | Process for preparing salts of omeprazole | |
| JP5086069B2 (ja) | 重硫酸アタザナビルおよび新規形態の製造方法 | |
| JPH02160767A (ja) | テトラヒドロピリジン酢酸誘導体、それらの製造方法、及びこれらの化合物の心臓保護のための使用 | |
| DD229990A5 (de) | Verfahren zur herstellung von neuen 2-piperazino-pteridine | |
| HK132695A (en) | Anhdrous, crystalline sodium salt of 5-chloro-3-(2-thenoyl)-2-oxindole-1-carboxamide | |
| US4260621A (en) | 3-Amino-4-phenyl-6-piperidino-1H-pyrazolo[3,4-b]-pyridines and salts thereof | |
| JP2012512145A (ja) | フリバンセリンの結晶性の塩形態 | |
| JPS5989671A (ja) | ２，５−ピペラジンジオン誘導体 | |
| KR101557832B1 (ko) | (ｒ)-3-플루오로페닐-3,4,5-트리플루오로벤질카르밤산 1-아자비시클로 [2.2.2]옥트-3-일 에스테르의 안정한 결정성 염 | |
| PL119444B1 (en) | Method for manufacturing racemic monohydrate of 3-/2-/3-tert.butylamino-2-hydroxypropoxy-/phenyl/-6-hydrazinpyridazine dihydrochloriderata 3-/2-/-3-iii-porjad.butilamino-2-gidroksipropoksi/genil/-6-gidrazinpiridozina | |
| PL194752B1 (pl) | Krystaliczna postać VI 5,6-dichloro-2-(izopropyloamino)-1-(ß-L-rybofuranozylo)-1H-benzimidazolu, sposób jej wytwarzania, kompozycja farmaceutyczna zawierająca krystaliczną postać i zastosowanie krystalicznej postaci | |
| DE3540952C2 (de) | 2-Piperazino-pteridine, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| US4167570A (en) | 2-Methyl-6-alkyl-11-aminoalkyl-6,11-dihydro-5H-pyrido(2,3-B)(1,5)benzodiazepin-5-ones and salts thereof | |
| JP7665219B2 (ja) | 化合物の塩、及び塩を含む医薬組成物 | |
| HRP20010904A2 (en) | Polymorphs of a crystalline azabicyclo[2,2,2]octan-3-amine citrate and their pharmaceutical compositions | |
| JPH01261387A (ja) | 新規なキノキサリン誘導体及びそれを含有する坑潰瘍剤 | |
| US3681394A (en) | Glyceryl-n-(substituted phenyl) anthranilates | |
| US3037981A (en) | Phenyltetrahydropyranylpiperazines | |
| KR100554704B1 (ko) | 1-메틸-5-ｐ-톨루오일피롤-2-아세트아미도아세트산 과이아실에스테르(ＭＥＤ 15) 화합물의 신규 결정동질이상 형태 | |
| KR20190005679A (ko) | 1-[2-(2,4-디메틸페닐설파닐)페닐]피페라진의 신규염 및 이의 제조방법 |